Sanofi

Company Overview

Sanofi is a pharmaceutical company that develops, manufactures, and distributes prescription medicines, vaccines, and consumer healthcare products. It manufactures and markets pharmaceuticals, vaccines, and animal health products. It has a wide global presence and dominates the U.S. and European markets.

Sanofi has an established presence in the cardiovascular drugs market, with a portfolio that includes lipid‑lowering agents, antihypertensives, and antithrombotic therapies. In cardiovascular care, its key products include Lovenox (enoxaparin sodium), an anticoagulant used to prevent and treat blood clots; Plavix (clopidogrel), an antiplatelet agent to reduce heart attack and stroke risk; Praluent (alirocumab), a PCSK9 inhibitor for lowering LDL cholesterol; Aprovel (irbesartan), an angiotensin II receptor blocker for hypertension; and Multaq (dronedarone), indicated for atrial fibrillation.

Financial Highlights (FY 2025)

Company's Business Segments

• Biopharma Segment : Biopharma segment comprises Specialty Care, General Medicines and Vaccines businesses for example Dupixent, Aubagio, Myozyme, Fabrazyme, Cerezyme, Eloctate, Alprolix, Nexviazyme, Jevtana, Sarclisa, Kevzara, Cerdelga, Aldurazyme,Cablivi and others
• Consumer Healthcare Segment : The Consumer Healthcare operating segment comprises commercial operations relating to Consumer Healthcare products, Research, development and production activities and global support functions dedicated to the segment. for example AllergyCough, Cold and Flu, Pain, Care, Digestive, Wellness, Physical and Mental Wellness, Personal Care and Others